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ABSTRACT 
Background 
Circadian rhythms are largely dysregulated in Major Depressive Disorder (MDD). The present 
review provides a summary of the findings about the role of clock genes in the etiology of MDD.  
Methods 
A careful search of articles on Pubmed, PsycINFO, Isi Web of Knowledge was performed in 
order to obtain a comprehensive review about the topic. 
Results 
The studies reported contrasting results about the association of different single nucleotide 
polymorphisms (SNPs) in clock genes and MDD. The most consistent result reported the 
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association between SNP rs2287161 of CRY1 and MDD development.  
Limitations 
Most of the published papers on the topic show bias as a prevalence of Asian ethnicity or not 
blinded conditions of laboratory experiments with respect to subjects’ conditions (healthy controls 
or MDD). 
Conclusion 
Further epigenetic and genome-wide studies are necessary to have a more clear idea about the 
role of clock genes in the etiology of MDD. 
 
Keywords: Major Depressive Disorder (MDD), Genetics, Clock genes 
 
1. Main Body 
Major Depressive Disorder (MDD) is characterized by several circadian abnormalities, 
although sleep-wake rhythm is certainly the most disrupted one (Turek, 2007). Common biological 
factors are probably involved both in mood symptoms and alteration of circadian rhythms of MDD 
patients, and this hypothesis is supported by the fact that: a) not all subjects with insomnia develop 
depression and b) vice versa hypnotic agents (e.g., zolpidem or ramelteon) do not address 
depressive symptoms (Turek, 2007). Clock genes dysregulation has been evocated as an important 
factor associated with the development of both insomnia and mood symptoms (Monteleone et al., 
2011). Probably insomnia and environmental factors such as work shift (Romano et al., 2017) cause 
changes in the expression of clock genes, which in turn determines the mood symptoms 
(Monteleone et al., 2011). Alternatively particular polimorphisms of clock genes may confer 
susceptibility to circadian abnormalities (e.g. sleep dysregulation) in MDD (Mendlewicz, 2009). Of 
note, not only the clock genes regulate sleep-wake rhythms, but also the propensity and timing of 
wakefulness; in addition a research has demonstrated as the abnormal expression of the clock gene 
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Rev-erbα (retinoic acid-related orphan receptor alpha) inhibits dopamine synthesis and 
consequently weakens dopamine neurotransmission (Chung et al., 2014). From a biological point of 
view, the two main molecules involved in the regulation of circadian rhythms are represented by 
protein Period (PER) and Cryptochrome (CRY). PER and CRY expression is regulated by the 
proteins CLOCK (Circadian Locomotor Output Cycles Kaput) and BMAL1 (Brain and muscle 
Arnt-like protein-1) whose transcription is in turn controlled by Rev-erbα. Finally PER may be 
inactivated by phosphorylation driven by casein kinase 1 epsilon (CK1ε) (Turek, 2007; Monteleone 
et al., 2011). All these genes regulate the internal clock in the suprachiasmatic nuclei of 
hypothalamus; this internal clock is in turn maintained in synchrony with the 24-h solar day by 
different molecules including melatonin or metabolic peptide hormones (Tsang et al., 2016). 
Purpose of the present review is to summarize the available findings about the role of clock 
genes in the etiology of MDD. In particular, we focused on the core clock genes that control the 
internal center clock in the suprachiasmatic nuclei. A careful search of articles on Pubmed, 
PsycINFO, Isi Web of Knowledge was performed in order to obtain a comprehensive review about 
the topic. The words MDD and unipolar depression have been matched with the terms “clock gene” 
and “circadian gene”. No restriction criteria were established for study design. Exclusion criteria 
consisted of: 1) animal studies; 2) samples with patients affected by a mood disorder different from 
MDD (e.g. bipolar depression); 3) off topic articles (e.g. those investigating the role of clock genes 
on antidepressant response). Only papers in English were included.  
Table 1 summarizes the results of the included studies and their effect sizes and it provides an 
evaluation of the quality of included studies according to Qualitative Assessment Tool for 
Quantitative Studies (Effective Public Health Practice Project). 
Four hundred and forty-one papers were initially identified, 190 were duplicates and 237 were 
excluded for above mentioned criteria. Fourteen papers satisfied the inclusion criteria (Figure 1). 
The first study about the role of polymorphisms of clock genes in the etiology of MDD was 
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published in 2008. The authors failed to find an association between single nucleotide 
polymorphisms (SNPs) of the nuclear receptor of Rev-erbα (NR1D1) and the diagnosis of MDD 
(Kishi et al., 2008). A subsequent study by the same research group confirmed these preliminary 
results as it failed to find any association between six tagging SNPs in CLOCK gene and MDD 
(Kishi et al., 2009). In contrast, the C allele in SNP rs2287161 of CRY1 gene was found to be more 
frequent in MDD subjects than in healthy controls, while the G allele in SNP rs11123857 of 
Neuronal PAS domain-containing protein 2 (NPAS2) gene was found to be more commonly 
associated with MDD patients than controls (Soria et al., 2010). NPAS2 is a transcriptional factor 
that acts similarly to CLOCK protein (Soria et al., 2010). Another research group found the SNP 
rs10997875 of sirtuin 1 (SIRT1) gene to be associated with the diagnosis of MDD. SIRT1 is an 
enzyme which regulates clock gene transcription in response to stress and aging (Kishi et al, 2010). 
In addition,  definite haplotypes of the ubiquitin-specific peptidase 46 (USP46) gene have been 
found to be more frequent in subjects affected by MDD than in healthy controls (Fukuo et al., 
2011). This protein is of particular interest because USP46 mutant mice have been found to have 
abnormalities in circadian behavioural rhythms (Fukuo et al., 2011). In contrast, a study by the same 
Japanese research group failed to find any association between CLOCK gene variants and MDD 
(Kishi et al. 2011) and these results were confirmed by a more recent research (Crisafulli et al., 
2013). Similarly, a subsequent study did not find the polymorphisms of CK1ε to be associated with 
a diagnosis of MDD (Matsunaga et al., 2012). Another research group measured the expression of 
RNA of different clock genes both in the brain of dead patients with MDD and healthy controls, and 
cyclic patterns were found to be much weaker in depressed patients than in controls as a 
consequence of shifted peak timing and probably disrupted phase relationships between the single 
circadian genes (Li et al., 2013a). Similar results were reported by another research that found 
disrupted diurnal rhythmic expression of clock genes such as PER, CRY, BMAL1, NPAS2 in 
subjects affected by MDD than in healthy controls (Li et al., 2013b). Furthermore, a study found 
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that MDD cases had higher frequency of the C allele in rs2287161 of CRY1 and of the T allele in 
rs738499 of Thyrotroph embryonic factor (TEF) than healthy controls (Hua et al., 2014). Of note, 
TEF is a clock-related gene that was found to contribute to the onset of sleep disturbances and 
mood symptoms in Parkinson disease (Hua et al., 2014). In contrast, a large-sample size study 
failed to find significant evidence for an association between MDD and different SNPs of both a 
core (n=21) and expanded (n=323) list of circadian genes (Byrne et al., 2014). In a more recent 
study the influence of gender and glucocorticoids on clock gene expression was hypothesized, and 
an association between SNP rs228697 of Per3 gene and MDD was reported in females, while 
between SNP rs1801260 of CLOCK gene and MDD in males (Shi et al., 2016). Finally, in a large 
Finnish sample MDD was found to be associated with the following SNPs: rs2292910 in CRY2, 
rs7123390 in CRY2 and rs 1488864 in PRKCDBP (Protein Kinase C Delta Binding Protein) 
(Kovanen et al., 2017). Of note PRKCDBP regulates the quantity of PER2 and CRY2 by reducing 
their metabolic stability (Kovanen et al., 2017). 
Most of association studies failed to find significant results between SNPs of clock genes and 
MDD, while abnormalities in the expression of these genes have been reported for different genes 
(Li et al., 2013b) in depressed subjects versus healthy controls. This result may be explained by the 
fact that alterations in the expression of clock genes might arise by epigenetic regulators which in 
turn are strongly influenced by environmental and lifestyle factors (e.g. pollution), hormones and 
inflammation (Romano et al., 2017).  It is thought that irregular lifestyle of predisposed subjects 
ultimately determines deficit in hippocampus neurogenesis by the mediator role of internal clock 
(Abrecht, 2017). One exception is represented by SNP rs2287161 of CRY1 which might confer a 
higher susceptibility to circadian dysregulation (e.g. early or delayed sleep phase) (Patke et al., 
2017) and MDD. One study reporting this association has an intermediate quality, while the other a 
low one; the reported effect sizes (d) are similar: 0.23 and 0.31 respectively (small/medium effect 
size) (Soria et al., 2010; Hua et al., 2014). Of note, loss of CRY1 gene in mice resulted in a 
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shortening of circadian cycle independently from light (Xu et al., 2015). If we consider published 
data about this topic for other mood disorders, it is surprising that few researches investigated the 
role of clock genes in the etiology of seasonal affective disorder (both unipolar and bipolar one). 
One of the best quality paper reported a specific polymorphism of NPAS2 gene (471 Leu/Ser) to be 
more frequently associated to the diagnosis of seasonal affective disorder (Johansson et al., 2003). 
This finding has not been subsequently replicated, and with regard to major depressive disorder 2 
(Byrne et al., 2014; Shi et al., 2016) out of three association studies failed to find an association 
between polymorphisms of NPAS2 and depressive illness. In contrast, more data have been 
published with regard to bipolar disorder; of note, polymorphisms of the gene of Aryl Hydrocarbon 
Receptor Nuclear Translocator Like Protein (ARNTL) and CRY2 would seem to increase 
susceptibility to bipolar illness or propensity to lithium response, while variants of Per3 have been 
associated with severe forms of bipolar disorder (Abreu and Bragança, 2015). It is interesting to 
notice that polimorphisms of CRY1 would seem to be more associated with a diagnosis of MDD, 
and variants of CRY2 with bipolar disorder. Previous research has demonstrated that dysregulation 
of CRY1 causes early sleep phase (typical of MDD), while abnormalities in the expression of CRY2 
provoke delayed sleep phase (typical of bipolar disorder) (Okamura et al., 1999). 
Finally, we have to consider that most of the published papers on the topic show bias as a 
prevalence of Asian ethnicity or not blinded conditions of laboratory experiments with respect to 
subjects’ conditions (healthy controls or MDD). These factors. together with the heterogeneity of 
studied polymorphisms. prevented form performing a meta-analysis of the available results. In 
addition. the samples of depressed patients in the different studies are extremely heterogeneous: in 
some cases first-episode major depressive patients have been selected (Li et al., 2013b), in other 
cases subjects with a major depressive episode of different severity or assessed with different 
diagnostic tools. For sure future research should focus on epigenetic aspects (e.g. methylation or 
microRNA) or genome-wide studies to get a better idea about the role of clock genes in MDD. If 
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the role of clock genes will be identified as relevant for at least specific subgroups of patients, new 
therapeutic strategies such as chronotherapeutics or social rhythm therapies will be decisive in 
ameliorating outcome of these subjects .  
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Figure 1. Prisma Diagram for systematic reviews
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Table 1.  Clock Genes and Major Depressive Disorder (MDD) 
Titles and abstracts screened 
N=251 Excluded: N=226 
Off topic: 103 
Other psychiatric diagnosis: 100 
Animal Studies: 23 
 
Full-text article screened 
N=25 
Included articles 
N=14 
Excluded: N=11 
Bipolar Depression: n=4 
Off topic: n=7 
Initial Search 
N=441 
Duplicates: n=190 
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Study Site 
Quality 
Global 
Rating 
Genes 
Sample 
(N) 
Primary Outcomes Effect size (d) 
Kishi  al., 2008 
(association study) 
Japan 3 NR1D1 682 
MDD: 322 
HC: 360 
(all Asians) 
 
Frequency of A allele in SNP rs939347 in 
MDD subjects versus healthy controls 
N.S. 0.02 
Frequency  of  G allele in SNP rs2071427 
in MDD subjects versus healthy controls 
N.S. 0.03 
Frequency  of A allele in SNP rs3744805  
in MDD subjects versus healthy controls 
N.S. 0.02 
Kishi et al., 2009 
(association study) 
Japan 3 CLOCK 1119 
MDD: 
324 
HC: 
795 
(all Asians) 
 
Frequency of  G allele in SNP rs11939815 
in MDD subjects versus healthy controls 
N.S. 0.06 
Frequency  of A allele in SNP rs11931061 
in MDD subjects versus healthy controls 
N.S. 0.08 
Frequency  of  A allele in SNP rs11133385 
in MDD subjects versus healthy controls 
N.S. 0.04 
Frequency  of G allele in SNP rs3736544 in 
MDD subjects versus healthy controls 
N.S. 0.06 
Frequency  of  T allele in SNP rs1801260 in 
MDD subjects versus healthy controls 
N.S. <0.01 
Frequency  of  T allele in SNP rs3749474  
in MDD subjects versus healthy controls 
N.S. 0.03 
Soria et al., 2010 
(association study) 
Catalonia 
(Spain) 
2 CRY1 
NPAS2 
775 
MDD: 
335 
HC: 
440 
(all 
Caucasians) 
Frequency  of  C allele in SNP rs2287161 
of CRY1  in MDD subjects versus healthy 
controls 
0.23 
Frequency  of  G allele in SNP rs11123857 
of NPAS2 in MDD subjects versus healthy 
controls 
0.23 
Kishi et al., 2010 
(association study) 
Japan 3 SIRT1 1216 
MDD: 
450 
HC: 
766 
(all Asians) 
Frequency of T allele in SNP rs10997875 in 
MDD subjects versus healthy controls 
0.18 
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Fukuo  et al., 2011 
(association study) 
Japan 3 USP46 1224 
MDD: 
432 
HC: 
792 
(all Asians) 
A-A-C haplotype in MDD patients versus 
healthy controls 
0.23 
G-A-A-C haplotype in MDD patients 
versus healthy controls 
0.20 
Kishi et al., 2011 
(association study) 
Japan 3 CLOCK 1028 
MDD: 
139 
HC: 
889 
(all Asians) 
 
Frequency of G allele in SNP rs3736544 in 
MDD subjects versus healthy controls 
N.S. 0.1 
Frequency of T allele in SNP rs1801260 in 
MDD subjects versus healthy controls 
N.S. 0.04 
Frequency of T allele in SNP rs3749474 in 
MDD subjects versus healthy controls 
N.S. 0.03 
Matsunaga et al., 2012 
(association study) 
Japan 3 CSNK1D* 
CSNK1E* 
2164 
MDD: 
452 
HC: 
1712 
(all Asians) 
Frequency of T allele in SNP rs4789846 of 
CSNK1D gene in MDD subjects versus 
healthy controls 
N.S. 0.09 
Frequency of C allele in SNP rs135745 of 
CSNK1E gene in MDD subjects versus 
healthy controls 
N.S. 0.09 
Crisafulli et al., 2013 
(association study) 
Genetic 
analyses 
conducted in 
Italy, but 
sample from 
Korea 
3 ABCB1, 
ABCB4 
TAP2, 
CLOCK 
CLPX1, 
CLPX2, 
SYN2, 
NRG1, 
5HTR1A, 
GPRIN2 
315 
MDD: 
145 
HC: 
170 
(all 
Koreans) 
 
Several SNPs None was 
statistically 
significant 
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Li et al., 2013a 
(expression study) 
United States 
of America 
1 Different 
Including  
BMAL1, 
PER1-2-3, 
NR1D1, 
DBP, 
BHLHE40, 
BHLHE41  
89 
MDD: 
34 
(33 
Caucasians, 
1 Asian) 
HC: 
55 
(50 
Caucasians, 
2 Asians, 2 
African 
Americans, 
1 Pacific 
Islander) 
 
 
Deviations of the predicted time of death 
according to clock gene transcription in 
MDD patients versus controls (indirect 
measure of the intensity of cyclic patterns 
and expressions of clock genes) 
0.13 
Li et al., 2013b 
(expression study) 
China 2 Expression 
of PER1, 
PER2, 
PER3, 
CRY1, 
BMAL1, 
NPAS2, 
GSK-3β 
24 
MDD: 
12 
HC: 
12 
(all 
Chinese) 
Expression of PER1 in MDD subjects 
versus healthy controls 
1.6 
Expression of PER2 in MDD subjects 
versus healthy controls 
0.20 
Expression of PER3 in MDD subjects 
versus healthy controls 
  0.51 
Expression of CRY1 in MDD subjects 
versus healthy controls 
1.3 
Expression of BMAL1 in MDD subjects 
versus healthy controls 
0.23 
Expression of NPAS2 in MDD subjects 
versus healthy controls 
1.6 
Expression of GSK-3β in MDD subjects 
versus healthy controls 
2.6 
Hua et al., 2014 
(association study) 
China 3 CRY1, 
CRY2, TEF 
590 
MDD: 
105 
HC: 
485 
(all 
Chinese) 
Frequency of C allele in SNP rs2287161 of 
CRY1 gene in MDD subjects versus 
healthy controls 
0.31 
Frequency of A allele in SNP rs10838524 
of CRY2 gene in MDD subjects versus 
healthy controls 
N.S. 0.20 
Frequency of T allele in SNP rs738499 of 
TEF gene in MDD subjects versus healthy 
controls 
0.44 
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Byrne et al., 2014 
(association study) 
Analyses 
performed in 
Australia, but 
cases from 
around the 
world 
(Psychiatric 
Genomics 
Consortium) 
2 Numerous 
circadian 
genes 
including 
CRY2, 
CSNK1D, 
CSNK1E, 
DBP, 
NPAS2, 
PER 1-2-3, 
NR1D1 
18759 
MDD: 
9240 
HC: 
9519 
(all 
Caucasians) 
 
Several SNPs None was 
statistically 
significant 
Shi et al., 2016 
(association study) 
United States 
of America 
2 ARNTL, 
CLOCK, 
NPAS2, 
PER3  
1368 
MDD: 592 
HC: 776 
(all 
Caucasians) 
 
 
Frequency of minor allele in SNP 
rs70965440 of ARNTL gene in MDD 
subjects versus healthy controls 
N.S. 0.06 
Frequency of minor allele in SNP 
rs1801260 of CLOCK gene in MDD 
subjects versus healthy controls 
N.S. 0.07 
Males: 0.24 
Frequency of minor allele in SNP 
rs4851377 of NPAS2 gene in MDD 
subjects versus healthy controls 
N.S. 0.1 
Frequency of minor allele in SNP 
rs34705978 of NPAS2 gene in MDD 
subjects versus healthy controls 
N.S. 0.07 
Frequency of minor allele in SNP rs228697 
of PER3 gene in MDD subjects versus 
healthy controls 
0.15 
Females: 0.13 
Males: N.S. 0.12 
Frequency of minor allele in SNP 
rs17031614 of PER3 gene in MDD subjects 
versus healthy controls 
0.13 
Kovanen et al., 2017 
(association study) 
Finland 2 CRY2, 
PRKCDBP 
4537 
MDD: 383 
HC: 4154 
(all Finnish) 
 
Frequency of minor allele in SNP 
rs1488864 of PRKCDBP gene in MDD 
subjects versus healthy controls 
0.25 
Frequency of minor allele in SNP 
rs7123390 of CRY2 gene in MDD subjects 
versus healthy controls 
0.14 
Frequency of minor allele in SNP 
rs2292910 of CRY2 gene in MDD subjects 
versus healthy controls 
0.14 
 
 
 
Legend: 
ABCB1: ATP Binding Cassette Subfamily B Member 1 
ABCB4: ATP Binding Cassette Subfamily B Member 4 
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ARNTL: Aryl Hydrocarbon Receptor Nuclear Translocator Like Protein 
BHLHE40: Basic Helix-Loop-Helix Family Member E40 
BHLHE41: Basic Helix-Loop-Helix Family Member E41 
BMAL1: Brain and Muscle ARNTL Protein-1 
CLOCK: Circadian Locomotor Output Cycles Kaput 
CLPX1: Caseinolytic Mitochondrial Matrix Peptidase Chaperone Subunit 1 
CLPX2: Caseinolytic Mitochondrial Matrix Peptidase Chaperone Subunit 2 
CRY1: Cryptochrome 1 
CRY2: Cryptochrome 2 
CSNK1D: Casein Kinase 1 Delta 
CSNK1E: Casein Kinase 1 Epsilon 
d: Cohen’s d effect size 
DBP: Albumin D Box-Binding Protein 
GPRIN2: G Protein Regulated Inducer Of Neurite Outgrowth 2 
HC: healthy controls 
MDD: Major Depressive Disorder 
N: number 
NPAS2: Neuronal PAS domain-containing protein 2 
NR1D1: Nuclear receptor of Rev-erbα  
NRG1: Neuroregulin1 
N.S: not statistically significant 
PER 1-2-3: Period 1-2-3 
PRKCDBP: protein kinase C delta binding protein  
SIRT1: Sirtuin1 
SNP: single nucleotide polymorphism 
SYN2: Synapsin 2 
TAP2: Antigen Peptide Transporter 2 
TEF: Thyrotroph Embryonic Factor 
USP46: Ubiquitin-Specific Peptidase 
5HTR1A: Serotonin Receptor 1A 
*
The most statistically significant SNPs have been reported 
Global rating (Effective Public Health Practice Project) was performed according to these criteria: 
1) Selection Bias (sample size power and number of subjects who agreed to participate into the study)  
2) Study Design (randomized versus non-randomized trials) 
3) Confounders (Yes/No) 
4) Blinding (Yes/No) 
5) Data collection methods (self reported data, observations by investigators or medical records) 
6) Presence of description of numbers and reasons for withdrawals and drop-outs 
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Case reports and case series have not been included 
Rate: 
1=strong (no weak ratings according to above criteria) 
2= moderate (one weak ranting according to above criteria) 
3= weak (two or more weak ratings according to above criteria) 
Highlights 
 Clock genes are thought to be involved in circadian abnormalities of Major Depressive Disorder 
 Abnormalities in the expression of clock genes have been reported in depressed subjects  
 SNP rs2287161 of CRY1 might confer a higher susceptibility to circadian dysregulation in Major 
Depression 
 Lifestyles, hormones or pollution are hypothesized to regulate the expression of clock genes  of 
depressed patients 
 
